Halozyme Appoints David Ramsay as President Drug Delivery
Halozyme Therapeutics appointed David Ramsay as President of Drug Delivery, a newly created role effective June 30, 2026. Mr. Ramsay, a former interim CFO and company veteran, will assume an enterprise-wide mandate to drive the growth of Halozyme's drug delivery technologies and report directly to CEO Helen Torley.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.